Clinical Pharmacokinetics Study of ART-123 in Disseminated Intravascular Coagulation (DIC) Subjects With Renal Impairment
NCT01704001
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Disseminated Intravascular Coagulation
Interventions
DRUG:
ART-123
Sponsor
Asahi Kasei Therapeutics Corporation